P. Brault

发表

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease

J. Bosq, J. Cosset, V. Ribrag, 1998, Bone Marrow Transplantation.

Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.

H. Tilly, B. Quesnel, E. Archimbaud, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: A large multicenter comparative study in patients with malignant lymphoma

J. Bourhis, O. Legrand, Sophie Park, 2007, Leukemia & lymphoma.

Jakking up Tumor Registry reporting of the myeloproliferative neoplasms

D. Decaudin, P. Brault, Marie, 2009 .

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

P. Couvreur, P. Rougier, J. Droz, 1992, Investigational New Drugs.

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Marc C. Jacob, M. Boubaya, J. Rossi, 2020, Leukemia.

Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice

S. Koscielny, P. Fenaux, V. Ribrag, 2000, Bone Marrow Transplantation.

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.

J. Bourhis, P. Cony-Makhoul, J. Reiffers, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34+ cells from poor mobilizer patients in NSG mice.

J. Bourhis, M. Arcangeli, S. Koscielny, 2020, Experimental hematology.

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

H. Dombret, S. Chevret, B. Quesnel, 2006, Leukemia.

Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1.

H. Tilly, D. Blaise, D. Maraninchi, 1991, Bone Marrow Transplantation.

Prevention of Menstruation with Leuprorelin (GnRH Agonist) in Women Undergoing Myelosuppressive Chemotherapy or Radiochemotherapy for Hematological Malignancies: a Pilot Study

J. Bourhis, P. Dietrich, J. Pico, 2001, Leukemia & lymphoma.

First line chemotherapy for patients with multiple myeloma with vad regimen followed by consolidation with high-dose chemoradiotherapy with peripheral stem cells autograft (PSCA): the experience of IGR center

J. Bourhis, J. Pico, M. Hayat, 1994 .

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000).

H. Dombret, A. Stamatoullas, A. Vekhoff, 2004 .